2021 AHA科学声明:肥胖与心血管疾病

2021-04-22 美国心脏协会 Circulation.2021 Apr 22;

2021年4月,美国心脏协会(AHA)发布了肥胖与心血管疾病的科学声明。本文总结了肥胖对动脉粥样硬化性心血管疾病、心力衰竭和心律失常特别是心源性猝死以及房颤诊断、临床管理以及预后的影响。

中文标题:

2021 AHA科学声明:肥胖与心血管疾病

英文标题:

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

发布机构:

美国心脏协会

发布日期:

2021-04-22

简要介绍:

2021年4月,美国心脏协会(AHA)发布了肥胖与心血管疾病的科学声明。本文总结了肥胖对动脉粥样硬化性心血管疾病、心力衰竭和心律失常特别是心源性猝死以及房颤诊断、临床管理以及预后的影响。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:肥胖与心血管疾病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=706e61c0020909a5, title=2021 AHA科学声明:肥胖与心血管疾病, enTitle=Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association, guiderFrom=Circulation.2021 Apr 22;, authorId=0, author=, summary=2021年4月,美国心脏协会(AHA)发布了肥胖与心血管疾病的科学声明。本文总结了肥胖对动脉粥样硬化性心血管疾病、心力衰竭和心律失常特别是心源性猝死以及房颤诊断、临床管理以及预后的影响。, cover=https://img.medsci.cn/2021430/1619714181927_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Thu Apr 22 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月,美国心脏协会(AHA)发布了肥胖与心血管疾病的科学声明。本文总结了肥胖对动脉粥样硬化性心血管疾病、心力衰竭和心律失常特别是心源性猝死以及房颤诊断、临床管理以及预后的影响。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=332, tagName=肥胖), TagDto(tagId=2529, tagName=心血管疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2529, guiderKeyword=心血管疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9808, appHits=210, showAppHits=0, pcHits=1026, showPcHits=9598, likes=1, shares=9, comments=6, approvalStatus=1, publishedTime=Fri Apr 30 01:23:50 CST 2021, publishedTimeString=2021-04-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 30 00:36:37 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 16:20:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:肥胖与心血管疾病.pdf)])
2021 AHA科学声明:肥胖与心血管疾病.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080686, encodeId=7c071080686a0, content=kky可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e55547022, createdName=ms1000001486828020, createdTime=Thu Dec 16 10:44:45 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966033, encodeId=76439660337e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6765479988, createdName=ms1000000664803717, createdTime=Sun May 16 15:51:53 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962334, encodeId=3dd79623348a, content=看看,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 02 19:47:11 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961812, encodeId=bac0961812a0, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/0a1fab2031bf41b48e4047acd213a6f2/6059ee64f6df408cabc030ae3914bf77.jpg, createdBy=10615485790, createdName=ms2000000761915616, createdTime=Fri Apr 30 16:15:45 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961732, encodeId=0213961e329e, content=还不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/b594a756d77e4171b5313e531ef89b43/31c000a8a97d4872b698c80fb8a33369.jpg, createdBy=624b2152505, createdName=大叔默默路过, createdTime=Fri Apr 30 09:00:37 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-12-16 ms1000001486828020

    kky可以

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080686, encodeId=7c071080686a0, content=kky可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e55547022, createdName=ms1000001486828020, createdTime=Thu Dec 16 10:44:45 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966033, encodeId=76439660337e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6765479988, createdName=ms1000000664803717, createdTime=Sun May 16 15:51:53 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962334, encodeId=3dd79623348a, content=看看,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 02 19:47:11 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961812, encodeId=bac0961812a0, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/0a1fab2031bf41b48e4047acd213a6f2/6059ee64f6df408cabc030ae3914bf77.jpg, createdBy=10615485790, createdName=ms2000000761915616, createdTime=Fri Apr 30 16:15:45 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961732, encodeId=0213961e329e, content=还不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/b594a756d77e4171b5313e531ef89b43/31c000a8a97d4872b698c80fb8a33369.jpg, createdBy=624b2152505, createdName=大叔默默路过, createdTime=Fri Apr 30 09:00:37 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-05-16 ms1000000664803717

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080686, encodeId=7c071080686a0, content=kky可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e55547022, createdName=ms1000001486828020, createdTime=Thu Dec 16 10:44:45 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966033, encodeId=76439660337e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6765479988, createdName=ms1000000664803717, createdTime=Sun May 16 15:51:53 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962334, encodeId=3dd79623348a, content=看看,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 02 19:47:11 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961812, encodeId=bac0961812a0, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/0a1fab2031bf41b48e4047acd213a6f2/6059ee64f6df408cabc030ae3914bf77.jpg, createdBy=10615485790, createdName=ms2000000761915616, createdTime=Fri Apr 30 16:15:45 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961732, encodeId=0213961e329e, content=还不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/b594a756d77e4171b5313e531ef89b43/31c000a8a97d4872b698c80fb8a33369.jpg, createdBy=624b2152505, createdName=大叔默默路过, createdTime=Fri Apr 30 09:00:37 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-05-02 ms2000001361349190

    看看,很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1080686, encodeId=7c071080686a0, content=kky可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e55547022, createdName=ms1000001486828020, createdTime=Thu Dec 16 10:44:45 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966033, encodeId=76439660337e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6765479988, createdName=ms1000000664803717, createdTime=Sun May 16 15:51:53 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962334, encodeId=3dd79623348a, content=看看,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 02 19:47:11 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961812, encodeId=bac0961812a0, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/0a1fab2031bf41b48e4047acd213a6f2/6059ee64f6df408cabc030ae3914bf77.jpg, createdBy=10615485790, createdName=ms2000000761915616, createdTime=Fri Apr 30 16:15:45 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961732, encodeId=0213961e329e, content=还不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/b594a756d77e4171b5313e531ef89b43/31c000a8a97d4872b698c80fb8a33369.jpg, createdBy=624b2152505, createdName=大叔默默路过, createdTime=Fri Apr 30 09:00:37 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-04-30 ms2000000761915616

    可以

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1080686, encodeId=7c071080686a0, content=kky可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66e55547022, createdName=ms1000001486828020, createdTime=Thu Dec 16 10:44:45 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966033, encodeId=76439660337e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b6765479988, createdName=ms1000000664803717, createdTime=Sun May 16 15:51:53 CST 2021, time=2021-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962334, encodeId=3dd79623348a, content=看看,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dffa5465843, createdName=ms2000001361349190, createdTime=Sun May 02 19:47:11 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961812, encodeId=bac0961812a0, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/0a1fab2031bf41b48e4047acd213a6f2/6059ee64f6df408cabc030ae3914bf77.jpg, createdBy=10615485790, createdName=ms2000000761915616, createdTime=Fri Apr 30 16:15:45 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961732, encodeId=0213961e329e, content=还不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/b594a756d77e4171b5313e531ef89b43/31c000a8a97d4872b698c80fb8a33369.jpg, createdBy=624b2152505, createdName=大叔默默路过, createdTime=Fri Apr 30 09:00:37 CST 2021, time=2021-04-30, status=1, ipAttribution=)]
    2021-04-30 大叔默默路过

    还不错

    0

拓展阅读

2014 AHA/ACC/HHS关于加强心血管疾病和共存疾病患者应用临床实践指南的策略

美国心脏协会(AHA,American Heart Association) · 2014-09-11

2014 BC临床指南:心血管疾病的一级预防

英国哥伦比亚临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2014-04-15

2015 AHA/ADA科学声明:成人2型糖尿病患者心血管疾病的预防(更新版)

美国糖尿病学会(ADA,American Diabetes Association) · 2015-08-05

2016 USPSTF建议声明:阿司匹林用于心血管疾病和结直肠癌的一级预防

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-04-12

2016 AHA/ASA政策声明:姑息治疗与心血管疾病和中风

美国心脏协会(AHA,American Heart Association) · 2016-08-08